News

Fourth Avenue Capital Expands Portfolio with New Acquisition

Fourth Avenue Capital Expands Portfolio with New Acquisition

Fourth Avenue Capital Expands Portfolio with Strategic Acquisition

Fourth Avenue Capital (FAC) has made a significant addition to its portfolio by acquiring Village on Broadway, a community featuring 148 units of Class B workforce housing. This property is a vital part of FAC's growing portfolio, which now includes 26 distinct properties, with three additional holdings in the Spokane–Coeur d'Alene metropolitan area.

About Village on Broadway

Constructed in 1996, Village on Broadway spans an impressive 7.3 acres and comprises 148 apartment units arranged within 13 buildings. The community presents a versatile selection of one-, two-, and three-bedroom apartment layouts, with an average size of 926 square feet per unit. Residents enjoy an array of parking options, including a total of 270 spaces that feature one carport designated for each apartment, along with available garage and surface parking.

Amenities and Features

Each unit is equipped with modern conveniences such as full-size washers and dryers, air conditioning, and built-in desks—an appealing feature, especially for individuals who work from home. The property fosters a well-designed living environment to accommodate various lifestyle needs.

Location Benefits

Located strategically between two urban centers, Village on Broadway offers easy access to I-90, ensuring that residents are never far from essential employment locations, shopping areas, and recreational opportunities. This advantageous positioning enhances the overall appeal of the community, making it a desirable place to live.

Future Developments

FAC has indicated plans for various capital improvements intended to enrich the Village on Broadway experience. These improvements will include enhancing the entrance aesthetics, upgrading current amenities, and refurbishing the exterior, aiming to boost both the value and attractiveness of the property.

Insights from Leadership

“Village on Broadway is a well-located asset in a growth market with differentiated floorplans,” expressed Davis Vaughn, Managing Partner at Fourth Avenue Capital. “As a local company, we are enthusiastic about this opportunity to invest within our community and uphold our dedication to quality housing in our home market.”

About Fourth Avenue Capital

Fourth Avenue Capital is a reputable real estate investment, development, and operational entity based in Seattle and Spokane. The company focuses on middle-market multifamily properties in the Pacific Northwest and boasts an impressive track record, having acquired over 1,400 units to date. Its development pipeline consists of more than 500 units, with associated costs exceeding $150 million. Currently, FAC manages assets valued at more than $400 million.

Fourth Avenue Capital is committed to expanding its portfolio through strategic acquisitions, utilizing strong relationships within the industry to pinpoint promising investment opportunities. With a focus on aligning investor interests and practicing sustainability, the company is dedicated to generating long-term value while positively influencing the communities it serves.

Frequently Asked Questions

What is Village on Broadway?

Village on Broadway is a 148-unit workforce housing community acquired by Fourth Avenue Capital, featuring a variety of apartment layouts.

What improvements are planned for Village on Broadway?

FAC plans to enhance the property with capital improvements, including upgrading amenities and refurbishing the building's exterior.

Where is Fourth Avenue Capital located?

Fourth Avenue Capital operates out of Seattle and Spokane, focusing on multifamily real estate assets in the Pacific Northwest.

How many properties does Fourth Avenue Capital manage?

Fourth Avenue Capital currently manages 26 properties within its real estate portfolio.

What types of housing does FAC specialize in?

FAC specializes in middle-market multifamily housing, providing a range of options for residents in desirable locations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 107

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 245

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 471

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 295

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 307

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 251

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 528

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Encouraged to Join Canopy Growth Class Action Suit

Updated Category News Views 338

Canopy Growth Corporation Class Action Lawsuit Opportunity Investors holding securities of Canopy Growth Corporation (NASDAQ: CGC) are presented with a crucial opportunity to join a class action lawsuit. This lawsuit involves a class period during which serious allegations have been raised against the company's managing officials. If you purchased Canopy Growth securities...

Continue Reading
Health Catalyst Plans for Q3 2025 Results Conference Call

Updated Category News Views 206

Upcoming Q3 2025 Operating Results Announcement Health Catalyst, Inc., known for its exceptional data and analytics technology for the healthcare sector, is preparing to unveil its operating results for the third quarter of 2025. This much-anticipated announcement will occur after market close on November 10, 2025. Health Catalyst is committed to transparency and...

Continue Reading
Intact Financial Enhances Cybersecurity with Major Investment

Updated Category News Views 125

Intact Financial Corporation's Strategic Cybersecurity Investment Intact Financial Corporation has announced a significant investment aimed at enhancing cybersecurity in Canada. This initiative includes a commitment of $2.25 million over five years towards the establishment of the Intact Cybersecurity Hub at the Université de Sherbrooke. This hub is set to become a...

Continue Reading
Hon Hai's Strategic Growth with Recent NTD 9.2 Billion Bonds

Updated Category News Views 149

Hon Hai's Corporate Bond Issuance Overview Hon Hai Precision Industry Co., Ltd., widely recognized as Foxconn, has recently issued three tranches of unsecured corporate bonds, amassing an impressive total of NTD 9.2 billion (approximately $309 million). This bold financial maneuver is instrumental for the company in the dynamically shifting landscape of the electronics...

Continue Reading
Sarkissian Bullock Team Facilitates Major Land Sale Success

Updated Category News Views 131

Sarkissian Bullock Team Achieves Historic Property Sale The esteemed Sarkissian Bullock Team, associated with Golden Gate Sotheby's International Realty, has reached a significant milestone by successfully facilitating the sale of the iconic Easton Point property to the Trust for Public Land. This landmark transaction highlights the team's dedication to land preservation...

Continue Reading